CAPILLARY TECHNOLOGIES EUROPE LIMITED

Company Registration Number:
03297240 (England and Wales)

Unaudited statutory accounts for the year ended 31 March 2025

Period of accounts

Start date: 1 April 2024

End date: 31 March 2025

CAPILLARY TECHNOLOGIES EUROPE LIMITED

Contents of the Financial Statements

for the Period Ended 31 March 2025

Directors report
Profit and loss
Balance sheet
Additional notes
Balance sheet notes

CAPILLARY TECHNOLOGIES EUROPE LIMITED

Directors' report period ended 31 March 2025

The directors present their report with the financial statements of the company for the period ended 31 March 2025

Principal activities of the company

The principal activities of the Company are those of providing cloud based intelligent customer engagement software solutions to retail chain operators.



Directors

The director shown below has held office during the whole of the period from
1 April 2024 to 31 March 2025

Anant Choubey


The director shown below has held office during the period of
1 April 2024 to 13 May 2024

Venkata Tadanki


The above report has been prepared in accordance with the special provisions in part 15 of the Companies Act 2006

This report was approved by the board of directors on
30 April 2025

And signed on behalf of the board by:
Name: Anant Choubey
Status: Director

CAPILLARY TECHNOLOGIES EUROPE LIMITED

Profit And Loss Account

for the Period Ended 31 March 2025

2025 2024


£

£
Turnover: 8,504,185 6,527,809
Cost of sales: ( 7,299,477 ) ( 6,121,829 )
Gross profit(or loss): 1,204,708 405,980
Distribution costs: 0 0
Administrative expenses: ( 954,339 ) ( 1,507,175 )
Other operating income: 0 0
Operating profit(or loss): 250,369 (1,101,195)
Interest receivable and similar income: 4,757 3,655
Interest payable and similar charges: 0 0
Profit(or loss) before tax: 255,126 (1,097,540)
Tax: ( 15,383 ) 0
Profit(or loss) for the financial year: 239,743 (1,097,540)

CAPILLARY TECHNOLOGIES EUROPE LIMITED

Balance sheet

As at 31 March 2025

Notes 2025 2024


£

£
Called up share capital not paid: 0 0
Fixed assets
Intangible assets:   0 0
Tangible assets: 3 10,809 28,500
Investments:   0 0
Total fixed assets: 10,809 28,500
Current assets
Stocks:   0 0
Debtors: 4 2,065,702 2,584,821
Cash at bank and in hand: 395,105 614,816
Investments:   0 0
Total current assets: 2,460,807 3,199,637
Prepayments and accrued income: 0 0
Creditors: amounts falling due within one year: 5 ( 1,626,524 ) ( 2,686,323 )
Net current assets (liabilities): 834,283 513,314
Total assets less current liabilities: 845,092 541,814
Creditors: amounts falling due after more than one year:   0 0
Provision for liabilities: 0 0
Accruals and deferred income: 0 0
Total net assets (liabilities): 845,092 541,814
Capital and reserves
Called up share capital: 389,409 389,409
Share premium account: 0 0
Other reserves: 118,369 54,834
Profit and loss account: 337,314 97,571
Total Shareholders' funds: 845,092 541,814

The notes form part of these financial statements

CAPILLARY TECHNOLOGIES EUROPE LIMITED

Balance sheet statements

For the year ending 31 March 2025 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

This report was approved by the board of directors on 30 April 2025
and signed on behalf of the board by:

Name: Anant Choubey
Status: Director

The notes form part of these financial statements

CAPILLARY TECHNOLOGIES EUROPE LIMITED

Notes to the Financial Statements

for the Period Ended 31 March 2025

  • 1. Accounting policies

    Basis of measurement and preparation

    These financial statements have been prepared in accordance with the provisions of Section 1A (Small Entities) of Financial Reporting Standard 102

    Turnover policy

    Revenue is measured based on the consideration to which the Company expects to be entitled in exchange for transferring promised goods or services to a customer, excluding amounts collected on behalf of third parties. Revenue is recognised when the Company satisfies a performance obligation by transferring a promised good or service to the customer, which is when the customer obtains control of the good or service. A performance obligation may be satisfied at a point in time or over time. The amount of revenue recognised is the amount allocated to the satisfied performance obligation.

    Tangible fixed assets depreciation policy

    Tangible fixed assets under the cost model are stated at historical cost less accumulated depreciation and any accumulated impairment losses. Historical cost includes expenditure that is directly attributable to bringing the asset to the location and condition necessary for it to be capable of operating in the manner intended by management. Depreciation is charged to allocate the cost of assets less their residual value over their estimated useful lives, using the written down value method. Depreciation is provided on the following basis: Computer Equipment 3 years Office equipment 5 years The assets’ residual values, useful lives and depreciation methods are reviewed, and adjusted prospectively if appropriate, or if there is an indication of a significant change since the last reporting date. Gains and losses on disposals are determined by comparing the proceeds with the carrying amount and are recognised in profit or loss

CAPILLARY TECHNOLOGIES EUROPE LIMITED

Notes to the Financial Statements

for the Period Ended 31 March 2025

  • 2. Employees

    2025 2024
    Average number of employees during the period 13 18

CAPILLARY TECHNOLOGIES EUROPE LIMITED

Notes to the Financial Statements

for the Period Ended 31 March 2025

3. Tangible assets

Land & buildings Plant & machinery Fixtures & fittings Office equipment Motor vehicles Total
Cost £ £ £ £ £ £
At 1 April 2024 50,225 50,225
Additions 0 0
Disposals ( 187 ) ( 187 )
Revaluations 0 0
Transfers 0 0
At 31 March 2025 50,038 50,038
Depreciation
At 1 April 2024 21,725 21,725
Charge for year 17,504 17,504
On disposals 0 0
Other adjustments 0 0
At 31 March 2025 39,229 39,229
Net book value
At 31 March 2025 10,809 10,809
At 31 March 2024 28,500 28,500

CAPILLARY TECHNOLOGIES EUROPE LIMITED

Notes to the Financial Statements

for the Period Ended 31 March 2025

4. Debtors

2025 2024
£ £
Trade debtors 1,139,014 1,583,576
Prepayments and accrued income 645,743 768,464
Other debtors 280,945 232,781
Total 2,065,702 2,584,821
Debtors due after more than one year: 0 0

CAPILLARY TECHNOLOGIES EUROPE LIMITED

Notes to the Financial Statements

for the Period Ended 31 March 2025

5. Creditors: amounts falling due within one year note

2025 2024
£ £
Bank loans and overdrafts 0 0
Amounts due under finance leases and hire purchase contracts 0 0
Trade creditors 697,371 1,863,126
Taxation and social security 310,203 346,620
Accruals and deferred income 244,761 88,633
Other creditors 374,189 387,944
Total 1,626,524 2,686,323